Heidi Crayton, MD, and Maria Lopes, MD, discuss the impact of multiple sclerosis on patients, families, and caregivers, differentiate relapsing forms (relapsing-remitting and primary progressive) from ...

For decades, multiple sclerosis (MS) research has focused largely on the inflammatory lesions visible on MRI scans. Yet new ...

Multiple sclerosis (MS) is a central nervous system immune-mediated inflammatory demyelinating disease. A relapsing-remitting course, a progressive disease course, or a combination of the two may ...

The 2024 McDonald criteria, published just before the 2025 ECTRIMS Congress, substantially expand criteria for a probable diagnosis of multiple sclerosis, experts report.

Researchers demonstrate the relationship between the rate of cognitive fatigue in MS and microstructural brain changes. The findings promise to advance development of clinical interventions for ...

Immunological memory - the ability to respond to a previously encountered antigen, or foreign substance, with greater speed and intensity on re-exposure is a hallmark of adaptive immunity. Innate ...

NEW YORK--(BUSINESS WIRE)--The Tisch MS Research Center of New York, the world’s largest independent research center focused on multiple sclerosis, has published groundbreaking new research ...

Amyloid pathology typical of Alzheimer's disease (AD) is 50% lower in patients with multiple sclerosis (MS) than in those without the condition, an analysis of plasma biomarker data shows.

I've been involved in MS care since before any treatments were available. I’m chief operating officer at Can Do Multiple Sclerosis, a nonprofit in the patient advocacy sphere of MS. I’m also a nurse ...